SCHEMBL10035407

SCHEMBL10035407

CCCCCCOB(OCCCCCC)c1cc2ccccc2c2c1sc1ccccc12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 3/20 0.33
MAPT P10636 3/20 0.33
CNR1 P21554 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
ATM Q13315 1/20 0.33
TLR8 Q9NR97 2/20 0.33
ALDH1A1 P00352 3/20 0.32
KDM4E B2RXH2 2/20 0.32
HTT P42858 2/20 0.32
MEN1 O00255 1/20 0.32
HCRTR1 O43613 1/20 0.32
HPGD P15428 1/20 0.32
KMT2A Q03164 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
NQO1 P15559 1/20 0.32
NQO2 P16083 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
FAAH O00519 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10035417 0.99 L3MBTL1 (0.34) CNR2MAPTCNR1L3MBTL1ATM
SCHEMBL10035398 0.95 ALDH1A1 (0.36) CNR2MAPTCNR1L3MBTL1ATM
SCHEMBL10035397 0.90 L3MBTL1 (0.36) CNR2MAPTCNR1L3MBTL1ATM
SCHEMBL10035406 0.85 L3MBTL1 (0.37) MAPTL3MBTL1ATMALDH1A1KDM4E
SCHEMBL10035414 0.81 KDM4E (0.37) MAPTL3MBTL1ATMALDH1A1KDM4E
SCHEMBL10035415 0.79 ALDH1A1 (0.40) MAPTL3MBTL1ATMALDH1A1KDM4E
SCHEMBL10035419 0.75 ALDH1A1 (0.36) MAPTL3MBTL1ATMALDH1A1KDM4E
SCHEMBL10035405 0.75 ALDH1A1 (0.36) MAPTL3MBTL1ATMALDH1A1KDM4E
SCHEMBL10035372 0.74 FAAH (0.39) MAPTTLR8ALDH1A1KMT2ANPSR1
SCHEMBL9950434 0.74 MAPT (0.42) MAPTL3MBTL1ATMALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674117-B2 Organoboron compound and method for manufacturing the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-03-18 US disclosed
US-8674117-B2 Organoboron compound and method for manufacturing the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-03-18 US disclosed
US-20120165550-A1 Organoboron Compound and Method for Manufacturing the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-06-28 US disclosed
US-20120165550-A1 Organoboron Compound and Method for Manufacturing the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165550-A1 Organoboron Compound and Method for Manufacturing the Same CYP2B6, CBR3, CBR1 CNR2 1987/4885MAPT 3496/4885CNR1 1082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.